Report Detail

Pharma & Healthcare Global Blood Compatible Polymers Market Professional Survey Report 2019

  • RnM3792373
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 106 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Polymers that are blood compatible consist of antithrombogenic biomaterial that does not include blood-soluble additives either. Biocompatible polymers are used to interface with biological systems to treat, evaluate, replace, and augment any organ, function, or tissue.
The blood compatible polymers market is driven by the biomedical and pharmaceutical end-use industries. Blood compatible polymers have various advantages over the other biomedical devices. They have been used extensively used over the last two decades. However, blood compatible polymers need to be made at a particular composition of polymers. Several techniques are used to gain desired properties of polymers to make them blood compatible. These techniques need highly skilled workers and adequate laboratory facilities. Hence, lack of skilled workers and laboratory facilities are likely to restrain the global blood compatible polymers market.

The global Blood Compatible Polymers market was valued at 1250 million US$ in 2018 and will reach 3590 million US$ by the end of 2025, growing at a CAGR of 14.1% during 2019-2025.
This report focuses on Blood Compatible Polymers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Compatible Polymers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Compatible Polymers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Compatible Polymers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AdvanSource Biomaterials Corporation
Sanofi S.A.
Baxter International Inc
ASM International
Biomaterial USA LLC.
Eastman Chemical Company
Evonik Industries AG
The Dow Chemical Company
Jiangsu Senolo Medical Technology
TOPAS Advanced Polymers GmbH

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Polyvinylchloride
Polytetrafluoroethylene
Polyethersulfone
Polyethylene
Polyetheretherketone
Polysulfone
Poly Propalene

Segment by Application
Biomedical and Blood Contacting Devices
Dental
Drug delivery


Table of Contents

    Executive Summary

      1 Industry Overview of Blood Compatible Polymers

      • 1.1 Definition of Blood Compatible Polymers
      • 1.2 Blood Compatible Polymers Segment by Type
        • 1.2.1 Global Blood Compatible Polymers Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Polyvinylchloride
        • 1.2.3 Polytetrafluoroethylene
        • 1.2.4 Polyethersulfone
        • 1.2.5 Polyethylene
        • 1.2.6 Polyetheretherketone
        • 1.2.7 Polysulfone
        • 1.2.8 Poly Propalene
      • 1.3 Blood Compatible Polymers Segment by Applications
        • 1.3.1 Global Blood Compatible Polymers Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Biomedical and Blood Contacting Devices
        • 1.3.3 Dental
        • 1.3.4 Drug delivery
      • 1.4 Global Blood Compatible Polymers Overall Market
        • 1.4.1 Global Blood Compatible Polymers Revenue (2014-2025)
        • 1.4.2 Global Blood Compatible Polymers Production (2014-2025)
        • 1.4.3 North America Blood Compatible Polymers Status and Prospect (2014-2025)
        • 1.4.4 Europe Blood Compatible Polymers Status and Prospect (2014-2025)
        • 1.4.5 China Blood Compatible Polymers Status and Prospect (2014-2025)
        • 1.4.6 Japan Blood Compatible Polymers Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Blood Compatible Polymers Status and Prospect (2014-2025)
        • 1.4.8 India Blood Compatible Polymers Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Blood Compatible Polymers
      • 2.3 Manufacturing Process Analysis of Blood Compatible Polymers
      • 2.4 Industry Chain Structure of Blood Compatible Polymers

      3 Development and Manufacturing Plants Analysis of Blood Compatible Polymers

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Blood Compatible Polymers Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Blood Compatible Polymers
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Blood Compatible Polymers Production and Capacity Analysis
      • 4.2 Blood Compatible Polymers Revenue Analysis
      • 4.3 Blood Compatible Polymers Price Analysis
      • 4.4 Market Concentration Degree

      5 Blood Compatible Polymers Regional Market Analysis

      • 5.1 Blood Compatible Polymers Production by Regions
        • 5.1.1 Global Blood Compatible Polymers Production by Regions
        • 5.1.2 Global Blood Compatible Polymers Revenue by Regions
      • 5.2 Blood Compatible Polymers Consumption by Regions
      • 5.3 North America Blood Compatible Polymers Market Analysis
        • 5.3.1 North America Blood Compatible Polymers Production
        • 5.3.2 North America Blood Compatible Polymers Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Blood Compatible Polymers Import and Export
      • 5.4 Europe Blood Compatible Polymers Market Analysis
        • 5.4.1 Europe Blood Compatible Polymers Production
        • 5.4.2 Europe Blood Compatible Polymers Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Blood Compatible Polymers Import and Export
      • 5.5 China Blood Compatible Polymers Market Analysis
        • 5.5.1 China Blood Compatible Polymers Production
        • 5.5.2 China Blood Compatible Polymers Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Blood Compatible Polymers Import and Export
      • 5.6 Japan Blood Compatible Polymers Market Analysis
        • 5.6.1 Japan Blood Compatible Polymers Production
        • 5.6.2 Japan Blood Compatible Polymers Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Blood Compatible Polymers Import and Export
      • 5.7 Southeast Asia Blood Compatible Polymers Market Analysis
        • 5.7.1 Southeast Asia Blood Compatible Polymers Production
        • 5.7.2 Southeast Asia Blood Compatible Polymers Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Blood Compatible Polymers Import and Export
      • 5.8 India Blood Compatible Polymers Market Analysis
        • 5.8.1 India Blood Compatible Polymers Production
        • 5.8.2 India Blood Compatible Polymers Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Blood Compatible Polymers Import and Export

      6 Blood Compatible Polymers Segment Market Analysis (by Type)

      • 6.1 Global Blood Compatible Polymers Production by Type
      • 6.2 Global Blood Compatible Polymers Revenue by Type
      • 6.3 Blood Compatible Polymers Price by Type

      7 Blood Compatible Polymers Segment Market Analysis (by Application)

      • 7.1 Global Blood Compatible Polymers Consumption by Application
      • 7.2 Global Blood Compatible Polymers Consumption Market Share by Application (2014-2019)

      8 Blood Compatible Polymers Major Manufacturers Analysis

      • 8.1 AdvanSource Biomaterials Corporation
        • 8.1.1 AdvanSource Biomaterials Corporation Blood Compatible Polymers Production Sites and Area Served
        • 8.1.2 AdvanSource Biomaterials Corporation Product Introduction, Application and Specification
        • 8.1.3 AdvanSource Biomaterials Corporation Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi S.A.
        • 8.2.1 Sanofi S.A. Blood Compatible Polymers Production Sites and Area Served
        • 8.2.2 Sanofi S.A. Product Introduction, Application and Specification
        • 8.2.3 Sanofi S.A. Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Baxter International Inc
        • 8.3.1 Baxter International Inc Blood Compatible Polymers Production Sites and Area Served
        • 8.3.2 Baxter International Inc Product Introduction, Application and Specification
        • 8.3.3 Baxter International Inc Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 ASM International
        • 8.4.1 ASM International Blood Compatible Polymers Production Sites and Area Served
        • 8.4.2 ASM International Product Introduction, Application and Specification
        • 8.4.3 ASM International Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Biomaterial USA LLC.
        • 8.5.1 Biomaterial USA LLC. Blood Compatible Polymers Production Sites and Area Served
        • 8.5.2 Biomaterial USA LLC. Product Introduction, Application and Specification
        • 8.5.3 Biomaterial USA LLC. Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eastman Chemical Company
        • 8.6.1 Eastman Chemical Company Blood Compatible Polymers Production Sites and Area Served
        • 8.6.2 Eastman Chemical Company Product Introduction, Application and Specification
        • 8.6.3 Eastman Chemical Company Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Evonik Industries AG
        • 8.7.1 Evonik Industries AG Blood Compatible Polymers Production Sites and Area Served
        • 8.7.2 Evonik Industries AG Product Introduction, Application and Specification
        • 8.7.3 Evonik Industries AG Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 The Dow Chemical Company
        • 8.8.1 The Dow Chemical Company Blood Compatible Polymers Production Sites and Area Served
        • 8.8.2 The Dow Chemical Company Product Introduction, Application and Specification
        • 8.8.3 The Dow Chemical Company Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Jiangsu Senolo Medical Technology
        • 8.9.1 Jiangsu Senolo Medical Technology Blood Compatible Polymers Production Sites and Area Served
        • 8.9.2 Jiangsu Senolo Medical Technology Product Introduction, Application and Specification
        • 8.9.3 Jiangsu Senolo Medical Technology Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 TOPAS Advanced Polymers GmbH
        • 8.10.1 TOPAS Advanced Polymers GmbH Blood Compatible Polymers Production Sites and Area Served
        • 8.10.2 TOPAS Advanced Polymers GmbH Product Introduction, Application and Specification
        • 8.10.3 TOPAS Advanced Polymers GmbH Blood Compatible Polymers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Blood Compatible Polymers Market

      • 9.1 Global Blood Compatible Polymers Market Trend Analysis
        • 9.1.1 Global Blood Compatible Polymers Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Blood Compatible Polymers Regional Market Trend
        • 9.2.1 North America Blood Compatible Polymers Forecast 2019-2025
        • 9.2.2 Europe Blood Compatible Polymers Forecast 2019-2025
        • 9.2.3 China Blood Compatible Polymers Forecast 2019-2025
        • 9.2.4 Japan Blood Compatible Polymers Forecast 2019-2025
        • 9.2.5 Southeast Asia Blood Compatible Polymers Forecast 2019-2025
        • 9.2.6 India Blood Compatible Polymers Forecast 2019-2025
      • 9.3 Blood Compatible Polymers Market Trend (Product Type)
      • 9.4 Blood Compatible Polymers Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Blood Compatible Polymers Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Blood Compatible Polymers. Industry analysis & Market Report on Blood Compatible Polymers is a syndicated market report, published as Global Blood Compatible Polymers Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Blood Compatible Polymers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,747.50
        4,121.25
        5,495.00
        3,234.00
        4,851.00
        6,468.00
        547,330.00
        820,995.00
        1,094,660.00
        292,215.00
        438,322.50
        584,430.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report